Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 1.00 |
| ▸ | CA2 | P00918 | 2/20 | 1.00 |
| ▸ | MMP1 | P03956 | 2/20 | 1.00 |
| ▸ | MMP2 | P08253 | 2/20 | 1.00 |
| ▸ | MMP9 | P14780 | 2/20 | 1.00 |
| ▸ | MMP8 | P22894 | 2/20 | 1.00 |
| ▸ | MMP13 | P45452 | 2/20 | 1.00 |
| ▸ | F2 | P00734 | 3/20 | 0.56 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.56 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.56 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | GFER | P55789 | 1/20 | 0.55 |
| ▸ | CYTH2 | Q99418 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL9033021 | 0.98 | CA1 (0.96) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL28191532 | 0.83 | CA1 (0.70) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL813077 | 0.79 | CA1 (0.65) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL29188855 | 0.78 | CA1 (0.64) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL15880861 | 0.77 | CA1 (0.63) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL12353346 | 0.77 | CA1 (0.63) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL812692 | 0.77 | CA1 (0.63) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL28192865 | 0.77 | CA1 (0.63) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL422151 | 0.77 | CA1 (0.63) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL9176627 | 0.77 | CA1 (0.62) | CA1CA2MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 593 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119751445-A | Preparation method of 6-ethynyl pyrazolo [1,5-a ] pyridine | 江南大学 | 2025-04-04 | — | — | CN | claimed |
| CN-115417875-B | Synthesis method of 5, 8-dimethoxy- [1,2,4] triazolo [1,5-C ] pyrimidine-2-amine | 山东华升新材料有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-112724099-B | (4-amino-5-imino-4, 5-dihydro-1, 3, 4-oxadiazol-2-yl) dinitromethane | 中国工程物理研究院化工材料研究所 | 2022-08-19 | — | — | CN | claimed |
| CN-112724133-B | Preparation method of 6-bromopyrazolo [1,5-a ] pyridine | 湖南复瑞生物医药技术有限责任公司 | 2022-03-25 | — | — | CN | claimed |
| CN-112724099-A | (4-amino-5-imino-4, 5-dihydro-1, 3, 4-oxadiazol-2-yl) dinitromethane | 中国工程物理研究院化工材料研究所 | 2021-04-30 | — | — | CN | claimed |
| EP-3126338-B1 | DISUBSTITUTED 5-FLUORO PYRIMIDINE DERIVATIVES CONTAINING A SULFONDIIMINE GROUP | Bayer Pharma AG (DE) | 2019-09-04 | — | — | EP | claimed |
| US-9790189-B2 | Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-10-17 | — | — | US | claimed |
| EP-3126338-A1 | DISUBSTITUTED 5-FLUORO PYRIMIDINE DERIVATIVES CONTAINING A SULFONDIIMINE GROUP | Bayer Pharma Aktiengesellschaft (DE) | 2017-02-08 | — | — | EP | claimed |
| US-20170015634-A1 | DISUBSTITUTED 5-FLUORO PYRIMIDINE DERIVATIVES CONTAINING A SULFONDIIMINE GROUP | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-01-19 | — | — | US | claimed |
| WO-2015150273-A1 | DISUBSTITUTED 5-FLUORO PYRIMIDINE DERIVATIVES CONTAINING A SULFONDIIMINE GROUP | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2015-10-08 | — | — | WO | claimed |
| EP-2254900-A1 | CHEMICAL MODIFICATION OF PROTEINS | ISIS Innovation Limited (GB) | 2010-12-01 | — | — | EP | claimed |
| WO-2009103941-A1 | CHEMICAL MODIFICATION OF PROTEINS | ISIS INNOVATION LIMITED (GB) | 2009-08-27 | — | — | WO | claimed |
| EP-1304326-A4 | SINGLE-STEP PROCESS FOR PREPARING 7,16-DEOXY-2-AZA-10-O-CLADINOSIL-12-O-DESOSAMINIL-4,5-DIHYDROXI-6-ETHYL-3,5,9,11,13,15-HEXAMETHYLBICYCLE (11.2.1)HEXADECA-1(2)-EN-8-ONA AND OBTAINING A NEW FORM OF 9-DESOXO-9A-METHYL-9A-AZA-9A-HOMOERYTHROMYCIN A | SILANES SA DE CV LAB (MX) | 2004-06-16 | — | — | EP | claimed |
| EP-1304326-A1 | SINGLE-STEP PROCESS FOR PREPARING 7,16-DEOXY-2-AZA-10-O-CLADINOSIL-12-O-DESOSAMINIL-4,5-DIHYDROXI-6-ETHYL-3,5,9,11,13,15-HEXAMETHYLBICYCLE (11.2.1)HEXADECA-1(2)-EN-8-ONA AND OBTAINING A NEW FORM OF 9-DESOXO-9A-METHYL-9A-AZA-9A-HOMOERYTHROMYCIN A | Laboratorio Silanes, S.A. de C.V. (MX) | 2003-04-23 | — | — | EP | claimed |
| WO-2002010144-A1 | SINGLE-STEP PROCESS FOR PREPARING 7,16-DEOXY-2-AZA-10-O-CLADINOSIL-12-O-DESOSAMINIL-4,5-DIHYDROXI-6-ETHYL-3,5,9,11,13,15-HEXAMETHYLBICYCLE (11.2.1)HEXADECA-1(2)-EN-8-ONA AND OBTAINING A NEW FORM OF 9-DESOXO-9A-METHYL-9A-AZA-9A-HOMOERYTHROMYCIN A | LABORATORIO SILANES, S.A. DE C.V. (MX) | 2002-02-07 | — | — | WO | claimed |
| EP-0176806-A1 | 1,2,4-Benzothiadiazinoxide derivatives, method for their preparation and medicaments containing them | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1986-04-09 | — | — | EP | claimed |
| JP-56039080-A | — | — | None | — | — | JP | disclosed |
| JP-56128769-A | — | — | None | — | — | JP | disclosed |
| US-3978052-A | ANTIHISTAMINIC, ANTITUSSIVE, ANTIINFLAMMATORY, DIURETIC | WARNER-LAMBERT COMPANY (US) | 1976-08-31 | — | — | US | disclosed |
| US-3974286-A | INSECTICIDES | ELI LILLY AND COMPANY (US) | 1976-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170015634-A1 | DISUBSTITUTED 5-FLUORO PYRIMIDINE DERIVATIVES CONTAINING A SULFONDIIMINE GROUP | DHFR, DPYD, TYMP | CA1 4649/4885CA2 4625/4885MMP1 4363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.